Adaptive design may hasten clinical trials.
Schmidt
Charlie
C
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D017321:Clinical Trials, Phase I as Topic / Q000379:methods; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D004334:Drug Administration Schedule; D015507:Drugs, Investigational / Q000008:administration & dosage*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D012107:Research Design; D013997:Time Factors
D000970:Antineoplastic Agents; D015507:Drugs, Investigational